DelSiTech Ltd responsible for delivery systems for oncolytic vectors in the EU STREP project
DelSiTech Ltd is responsible for delivery systems for oncolytic vectors (OV) in the EU FP6 STREP project launched in January 2006. DelSiTech focuses on developing a special delivery technology for the in vivo delivery of OVs to optimise their targeting properties, to extend their safety and their efficiency. Total funding for the consortium is 3.7 million euros.
delsitech.com
